BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22699458)

  • 1. Autoimmunity, dendritic cells and relevance for Parkinson's disease.
    Koutsilieri E; Lutz MB; Scheller C
    J Neural Transm (Vienna); 2013 Jan; 120(1):75-81. PubMed ID: 22699458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated immune cells in Parkinson's disease.
    Cao JJ; Li KS; Shen YQ
    J Neuroimmune Pharmacol; 2011 Sep; 6(3):323-9. PubMed ID: 21553347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
    Jiang T; Li G; Xu J; Gao S; Chen X
    Front Immunol; 2018; 9():2047. PubMed ID: 30319601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells in Parkinson's disease: Regulatory role and therapeutic potential.
    Mula A; Yuan X; Lu J
    Eur J Pharmacol; 2024 Aug; 976():176690. PubMed ID: 38815784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory immune cell subsets in autoimmunity.
    La Cava A
    Autoimmunity; 2011 Feb; 44(1):1-2. PubMed ID: 20670121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
    Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A
    Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the Neurodegenerative Process Associated to Parkinson's Disease by CD4+ T-cells.
    González H; Contreras F; Pacheco R
    J Neuroimmune Pharmacol; 2015 Dec; 10(4):561-75. PubMed ID: 26018603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
    Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
    Front Immunol; 2019; 10():303. PubMed ID: 30858851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease, autoimmunity, and olfaction.
    Benkler M; Agmon-Levin N; Shoenfeld Y
    Int J Neurosci; 2009; 119(12):2133-43. PubMed ID: 19916845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of innate and adaptive immunity in Parkinson's disease.
    Kannarkat GT; Boss JM; Tansey MG
    J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromelanin is an immune stimulator for dendritic cells in vitro.
    Oberländer U; Pletinckx K; Döhler A; Müller N; Lutz MB; Arzberger T; Riederer P; Gerlach M; Koutsilieri E; Scheller C
    BMC Neurosci; 2011 Nov; 12():116. PubMed ID: 22085464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive immune responses in Parkinson's disease.
    Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
    Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic benefits of regulating inflammation in autoimmunity.
    Nikoopour E; Schwartz JA; Singh B
    Inflamm Allergy Drug Targets; 2008 Sep; 7(3):203-10. PubMed ID: 18782028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory response in Parkinson's disease (Review).
    Yan J; Fu Q; Cheng L; Zhai M; Wu W; Huang L; Du G
    Mol Med Rep; 2014 Nov; 10(5):2223-33. PubMed ID: 25215472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial antigen presentation: a mechanism linking Parkinson's disease to autoimmunity.
    Fahmy AM; Boulais J; Desjardins M; Matheoud D
    Curr Opin Immunol; 2019 Jun; 58():31-37. PubMed ID: 30904790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
    Lee Y; Lee S; Chang SC; Lee J
    Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.